Use of Avandia & rapid weight loss or gain may be an indicator of more serious conditions.
*** Avandia® Labeling Update 2/4/11: The FDA has notified healthcare professionals and patients that information on the cardiovascular risks (including heart attack) of Avandia (rosiglitazone) has been added to the physician labeling and patient Medication Guide. Additionally, the drug labels have been revised to state that rosiglitazone and rosiglitazone-containing medicines should only be used:
- In patients already being treated with these medicines
- In patients whose blood sugar cannot be controlled with other anti-diabetic medicines and who, after consulting with their healthcare professional, do not wish to use pioglitazone-containing medicines (Actos, Actoplus Met, Actoplus Met XR, or Duetact).
What’s the problem?
Use of Avandia and weight loss or gain that occurs rapidly may be an indicator of more serious conditions such as heart or liver problems. Because Avandia and weight loss are important concerns for type 2 diabetes patients, it is important to carefully manage a comprehensive approach to this condition. Regular liver monitoring tests should be taken to make sure that Avandia is working for you. Additionally, exercise and healthy eating patterns can make taking Avandia and weight loss possible.
Because Avandia and weight loss can be a sign of more serious concerns, it is important to be aware of how Avandia is affecting you. The FDA has found that Avandia may be a safer alternative to Rezulin, but there are still very serious side effects associated with Avandia. These include heart failure, liver failure, and hepatitis.
These more serious side effects have been played down by GlaxoSmithKline, and have led to recent lawsuits over the company’s failure to disclose this information. If you have experienced problems with Avandia and weight loss, or any other serious side effects, you may be eligible to file a legal claim to recover damages you may have suffered.